The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief of eye redness due to minor irritation in individuals aged 12 years and ...
The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.
Subcutaneous interleukin-6 receptor antagonist approved for adult patients with active or inactive thyroid eye disease regardless of disease duration.
No over-the-counter product can treat genital herpes or any other sexually transmitted infection, regulators say ...
Protein (sodium and calcium caseinates, L-arginine), carbohydrate (corn syrup, fructose), fat (high oleic sunflower, MCT, corn oils), L-carnitine, taurine, vitamins ...
Immediate symptomatic relief and long-term neuroimmunomodulation seen with acupressure combined with pharmacotherapy ...
The expansion marks the first therapy approved for patients with BCG-unresponsive non-muscle-invasive bladder cancer presenting with papillary-only disease.
A nationwide voluntary recall has been issued for 22 lots of Argatroban Injection due to the presence of multi-material particulate contamination, posing potential life-threatening risks.
Dr Hamzavi discussed how to navigate conversations with patients with HS regarding common misconceptions, expectations with ...
Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...
Vanda Pharmaceuticals has paused the clinical program for VQW-765 after a phase 3 trial evaluating the drug for social anxiety disorder failed to show significant distress reduction compared with ...
Real-world GPP data show low uptake of targeted IL-36 inhibitors and persistent reliance on corticosteroids and non-GPP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results